6 completed. 6 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 6 | Completed 6 |
| Phase 2 | 2 | Completed 2 |
Follow Arteritis: new trials by email Literature Review of Arteritis trials Research Report on Arteritis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Intravenous Secukinumab in Patients With GCA or PMR Secukinumab - Giant Cell Arteritis, Polymyalgia Rheumatica | Phase 1 | Completed | Novartis Pharmaceuticals | 65 | 2024-03-27 | 2026-04-01 |
| Comparative Study of 3 Tocilizumab Products in Normal Healthy Volunteeers Tocilizumab Prefilled Syringe - Rheumatoid Arthritis, Giant Cell Arteritis | Phase 1 | Completed | Syneos Health | 300 | 2021-05-31 | 2024-01-05 |
| A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Tocilizumab (TCZ) Administered to Participants With Giant Cell Arteritis (GCA). Tocilizumab - Giant Cell Arteritis | Phase 1 | Completed | Hoffmann-La Roche | 24 | 2019-08-05 | 2021-12-22 |
| Giant Cell Arteritis Treatment With Ultra-short Glucocorticoids and Tocilizumab Tocilizumab, Glucocorticoids - Giant Cell Arteritis | Phase 1 / Phase 2 | Completed | Insel Gruppe AG, University Hospital Bern | 18 | 2018-12-01 | 2021-06-22 |
| Safety Study of Suprachoroidal Triamcinolone Acetonide Via Microneedle to Treat Uveitis triamcinolone acetonide (Triesence®) - Uveitis, Intermediate Uveitis | Phase 1 / Phase 2 | Completed | Clearside Biomedical, Inc. | 11 | 2013-02-01 | 2021-02-21 |
| MRI Superficial Temporal Artery MRI - Temporal Arteritis | Phase 1 | Completed | University Health Network, Toronto | 5 | 2003-04-01 | 2007-04-23 |
Giant Cell Arteritis (6) · Arthritis, Rheumatoid (1) · Choroidal Effusions (1) · Inflammation (1) · Ophthalmia, Sympathetic (1) · Panuveitis (1) · Polymyalgia Rheumatica (1) · Uveitis (1) · Uveitis, Intermediate (1) · Uveitis, Posterior (1)
Autoimmune Diseases (6) · Autoimmune Diseases of the Nervous System (6) · Brain Diseases (6) · Cardiovascular Diseases (6) · Central Nervous System Diseases (6) · Cerebrovascular Disorders (6) · Immune System Diseases (6) · Nervous System Diseases (6) · Skin Diseases (6) · Skin Diseases, Vascular (6) · Skin and Connective Tissue Diseases (6) · Vascular Diseases (6) · Vasculitis (6) · Vasculitis, Central Nervous System (6)
tocilizumab (3) · Adrenal Cortex Hormones (1) · Glucocorticoids (1) · Triamcinolone (1) · Triamcinolone Acetonide (1) · secukinumab (1)
Clearside Biomedical, Inc. (1) · Hoffmann-La Roche (1) · Insel Gruppe AG, University Hospital Bern (1) · Novartis Pharmaceuticals (1) · Syneos Health (1) · University Health Network, Toronto (1)
Switzerland (3) · United States (2) · Australia (1) · Canada (1) · Czechia (1) · India (1) · Italy (1) · New Zealand (1) · Portugal (1) · Spain (1)
Narinder Paul, FRCP C (1) · Peter Villiger, Prof (1) · Thomas Ciulla, MD (1)
PMID 27980877, PMID 34117737, PMID 35659282, PMID 37287970, PMID 38287611
2018 (2), 2023 (1)